NANOVIRICIDES, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
NANOVIRICIDES, INC. (NNVC) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$164.98 thousand for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-09-28
- NANOVIRICIDES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$52.10K.
- NANOVIRICIDES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-06-30 was -$1.20M.
- NANOVIRICIDES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-03-31 was $749.17K.
- NANOVIRICIDES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-12-31 was -$4.75M.
- NANOVIRICIDES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$164.98K.
- NANOVIRICIDES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$476.37K.
- NANOVIRICIDES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$5.76M.
- NANOVIRICIDES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$5.23M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 104 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 107 month |
|---|---|---|---|---|---|---|
| 2017-06-30 | -$164.98K 10-K · filed 2017-09-28 | |||||
| 2016-06-30 | -$52.10K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$476.37K 10-K · filed 2017-09-28 | ||||
| 2016-03-31 | -$424.27K 10-Q · filed 2016-05-10 | |||||
| 2015-06-30 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$446.78K derived: sum of 2 quarters · filed 2017-09-28 | -$5.20M derived: sum of 3 quarters · filed 2017-09-28 | -$5.76M 10-K · filed 2017-09-28 | ||
| 2015-03-31 | $749.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | -$4.00M derived: sum of 2 quarters · filed 2016-05-10 | -$4.56M 10-Q · filed 2016-05-10 | -$5.18M derived: sum of 4 quarters · filed 2016-09-16 | ||
| 2014-12-31 | -$4.75M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-02-25 | -$5.31M 10-Q · filed 2015-02-25 | -$5.93M derived: sum of 3 quarters · filed 2016-09-16 | -$7.19M derived: sum of 4 quarters · filed 2016-09-16 | ||
| 2014-09-30 | -$562.51K 10-Q/A · filed 2015-02-23 | -$1.18M derived: sum of 2 quarters · filed 2016-09-16 | -$2.44M derived: sum of 3 quarters · filed 2016-09-16 | -$2.52M derived: sum of 4 quarters · filed 2016-09-16 | ||
| 2014-06-30 | -$612.89K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-16 | -$1.87M derived: sum of 2 quarters · filed 2016-09-16 | -$1.96M derived: sum of 3 quarters · filed 2016-09-16 | -$5.23M 10-K · filed 2016-09-16 | ||
| 2014-03-31 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | -$1.34M derived: sum of 2 quarters · filed 2015-05-15 | -$4.62M 10-Q · filed 2015-05-15 | -$4.68M derived: sum of 4 quarters · filed 2015-09-14 | -$7.58M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$83.99K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-02-25 | -$3.36M 10-Q · filed 2015-02-25 | -$3.42M derived: sum of 3 quarters · filed 2015-09-14 | -$4.42M derived: sum of 4 quarters · filed 2015-09-14 | -$6.32M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$3.27M 10-Q/A · filed 2015-02-23 | -$3.34M derived: sum of 2 quarters · filed 2015-09-14 | -$4.34M derived: sum of 3 quarters · filed 2015-09-14 | |||
| 2013-06-30 | -$64.93K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | -$1.06M derived: sum of 2 quarters · filed 2015-09-14 | -$1.06M 10-K · filed 2015-09-14 | |||
| 2013-03-31 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | -$1.00M 10-Q · filed 2014-05-15 | ||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | |||||
| 2012-06-30 | -$58.55K 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |